Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cerilliant
Dow
UBS
AstraZeneca
McKinsey
Mallinckrodt
Boehringer Ingelheim
US Department of Justice

Generated: November 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020156

« Back to Dashboard

NDA 020156 describes VIDEX, which is a drug marketed by Bristol Myers Squibb and Bristol-myers Squibb and is included in four NDAs. It is available from one supplier. Additional details are available on the VIDEX profile page.

The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the didanosine profile page.
Summary for 020156
Tradename:VIDEX
Applicant:Bristol-myers Squibb
Ingredient:didanosine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020156
Medical Subject Heading (MeSH) Categories for 020156
Suppliers and Packaging for NDA: 020156
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIDEX didanosine FOR SOLUTION;ORAL 020156 NDA Bristol-Myers Squibb Company 0087-6632 0087-6632-41 1 BOTTLE in 1 CARTON (0087-6632-41) > 200 mL in 1 BOTTLE
VIDEX didanosine FOR SOLUTION;ORAL 020156 NDA Bristol-Myers Squibb Company 0087-6633 0087-6633-41 1 BOTTLE in 1 CARTON (0087-6633-41) > 400 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrength10MG/ML
Approval Date:Oct 9, 1991TE:RLD:Yes

Expired US Patents for NDA 020156

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol-myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020156-001 Oct 9, 1991 ➤ Sign Up ➤ Sign Up
Bristol-myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020156-001 Oct 9, 1991 ➤ Sign Up ➤ Sign Up
Bristol-myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020156-001 Oct 9, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Dow
Cipla
Julphar
Boehringer Ingelheim
Chubb
Deloitte
Teva
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.